Sio Capital Management »

Context Therapeutics shares owned by Sio Capital Management

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.7M 1.3M 2.01

More positions owned by Sio Capital Management

Insmed Com Par $.01 Put Option (INSM)
Labcorp Holdings Com Shs (LH)
Teleflex Incorporated (TFX)
Zimmer Holdings (ZBH)
Smith & Nephew Spdn Adr New (SNN)
Pacira Pharmaceuticals Put Option (PCRX)
Organon & Co Common Stock (OGN)
GSK Sponsored Adr (GSK)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Vaxart Com New (VXRT)
Tyra Biosciences (TYRA)
Abbott Laboratories (ABT)
Cigna Corp (CI)
Kenvue (KVUE)
Disc Medicine (IRON)

View all positions for Sio Capital Management

Top funds holding Context Therapeutics

Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Vanguard Group
Blackstone Group
Nantahala Capital Management
Franklin Resources
Alyeska Investment Group
Woodline Partners
Sio Capital Management
Affinity Asset Advisors
BlackRock
BlackRock

View all funds holding Context Therapeutics